TRI, experts in Risk-Based Quality Management, today announced launch of TRIAL.OS, new operating system for intelligent clinical trials. TRIAL.OS signals start of new era of AI-augmented clinical research, elevating study teams with data insights and driving trial efficiency with dramatically accelerated outcomes. TRIAL.OS democratises value allowing companies access to suite of targeted applications only paying for what they use whether as standalone app, as part of OPRA RBQM platform, or alongside existing technologies.
TRIAL.OS poses previously unasked question: What if your data could talk? What if it could tell you where risks with trial are, why, and provide guidance as to what to do about them?
OS in TRIAL.OS stands for operating system and meant literally. If going to change industry have to change how work internally and how help customers work. Challenged how envision, develop, commercialise and allow access to solutions. Asked what opportunities does AI allow to capture never able to before and transformed business to take advantage.
TRIAL.OS moves teams from operational trial management to intelligent trial management. It elevates expert judgment instead of automating it, and that changes how trials get designed, monitored and delivered. New model from protocol to database lock built around six functions that move teams from signal overload to guided action. Each app starts with real problem worth solving so teams can reach value needed without paying for technology they do not.
RBQM largely been preserve of organizations with budget to commit to permanent technology platform. TRIAL.OS changes that and brings value within reach of any company running clinical trials one app at a time.
TRIAL.OS developed with customers working alongside TRI, running apps against own protocols and shaping what gets built next. TRIAL.OS will ship new capabilities every month. Ideas raised by clients prototyped in weeks rather than queued for distant roadmap, then taken through same validated development process as everything else TRI builds.
TRIAL.OS developed under same quality management system as OPRA in line with ICH E6(R3), 21 CFR Part 11, GCP and GDPR. Every output is draft that team reviews and owns, and governed by AI framework covering human oversight and EU AI Act alignment.
About TRI
TRI has spent 13 years helping sponsors and CROs deliver better-quality clinical trials through Risk-Based Quality Management. More than 500 global clinical trials have run on OPRA, TRI's RBQM platform, and more than half of TRI's people have worked at a sponsor or a CRO before joining.
